This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: University of Florida Research Foundation Inc.. Active years: 2017-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2023
Title: Joseph Larkin: Innovator in Autoimmune Disease Treatment
Introduction
Joseph Larkin is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of autoimmune disease treatment, holding 2 patents that focus on innovative therapeutic approaches.
Latest Patents
Larkin's latest patents include developments in SOCS mimetics for the treatment of diseases. The subject invention concerns peptide mimetics of SOCS proteins and methods of use. In one embodiment, a peptide mimetic of the invention binds to a SOCS1 and a SOCS3 target protein. A specific embodiment includes a peptide mimetic that comprises the amino acid sequence of SEQ ID NO:1 and/or SEQ ID NO:2 and/or SEQ ID NO:51, or a functional fragment or variant thereof. Furthermore, the invention allows for multiple copies of the mimetic sequence, enhancing its therapeutic potential. The subject invention also pertains to methods of treating and/or preventing autoimmune conditions and/or disorders, including the treatment of systemic lupus erythematosus (SLE) in both humans and animals. Additionally, Larkin's work includes compositions for the treatment and prevention of Type 1 Diabetes (T1D), utilizing antigen presenting cells (APC) that have been pulsed with bacteria or their components to inhibit diabetes-promoting T cells.
Career Highlights
Joseph Larkin is affiliated with the University of Florida Research Foundation, Incorporated, where he continues to advance research in autoimmune diseases. His work has garnered attention for its innovative approaches to complex medical conditions.
Collaborations
Larkin collaborates with esteemed colleagues, including Mark A Atkinson and Howard Marcellus Johnson, contributing to a rich environment of research and innovation.
Conclusion
Joseph Larkin's contributions to the field of autoimmune disease treatment through his innovative patents highlight his role as a leading inventor. His work not only advances scientific understanding but also offers hope for effective treatments for challenging health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile